Search research articles
Contact Us
Filters
Showing results (321-330 of 408) with videos related to
Page
of 41
Sort By:
Cytometry. Part a : the Journal of the International Society for Analytical Cytology
|
April 11, 2020
Handling and Processing of Blood Specimens from Patients with COVID-19 for Safe Studies on Cell Phenotype and Cytokine Storm
Andrea Cossarizza, Lara Gibellini, Sara De Biasi, et al.
Medicine
|
November 3, 2021
Has COVID-19 changed the approach to HIV diagnosis?: A multicentric Italian experience
Maria Mazzitelli, Arturo Ciccullo, Gianmaria Baldin, et al.
AIDS (London, England)
|
November 8, 2017
Switching from a ritonavir-boosted protease inhibitor to a dolutegravir-based regimen for maintenance of HIV viral suppression in patients with high cardiovascular risk
José M Gatell, Lambert Assoumou, Graeme Moyle, et al.
Clinical Transplantation
|
December 2, 2017
Sofosbuvir plus daclatasvir with or without ribavirin is safe and effective for post-transplant hepatitis C recurrence and severe fibrosis and cirrhosis: A prospective study
Raffaella Lionetti, Vincenza Calvaruso, Paola Piccolo, et al.
The New England Journal of Medicine
|
August 9, 2008
HHV-6A in syncytial giant-cell hepatitis
Leonardo Potenza, Mario Luppi, Patrizia Barozzi, et al.
Viruses
|
December 23, 2023
Bone Mineral Density and Trabecular Bone Score Changes throughout Menopause in Women with HIV
Jovana Milic, Stefano Renzetti, Denise Morini, et al.
Nutrients
|
September 23, 2022
Modifications of Chest CT Body Composition Parameters at Three and Six Months after Severe COVID-19 Pneumonia: A Retrospective Cohort Study
Giulia Besutti, Massimo Pellegrini, Marta Ottone, et al.
HIV Clinical Trials
|
August 22, 2014
Relationship between health-related quality of life measures and high HIV viral load in HIV-infected triple-class-experienced patients
Raffaella Bucciardini, Katherina Pugliese, Liliana Weimer, et al.
Open Forum Infectious Diseases
|
January 19, 2026
Bimonthly Administered Long-Acting Cabotegravir and Rilpivirine Are Highly Effective and Well-Tolerated in People With Human Immunodeficiency Virus Above 65 Years
Andrea Calcagno, Caterina Candela, Agostino Riva, et al.
AIDS (London, England)
|
February 26, 2021
Dolutegravir is not associated with weight gain in antiretroviral therapy experienced geriatric patients living with HIV
Giovanni Guaraldi, Stefano Calza, Jovana Milic, et al.
Page
of 41
Search research articles
Search
Showing results (321-330 of 408) with videos related to
Sort By:
Page
of 41
Cytometry. Part a : the Journal of the International Society for Analytical Cytology
|
April 11, 2020
Handling and Processing of Blood Specimens from Patients with COVID-19 for Safe Studies on Cell Phenotype and Cytokine Storm
Andrea Cossarizza, Lara Gibellini, Sara De Biasi, et al.
Medicine
|
November 3, 2021
Has COVID-19 changed the approach to HIV diagnosis?: A multicentric Italian experience
Maria Mazzitelli, Arturo Ciccullo, Gianmaria Baldin, et al.
AIDS (London, England)
|
November 8, 2017
Switching from a ritonavir-boosted protease inhibitor to a dolutegravir-based regimen for maintenance of HIV viral suppression in patients with high cardiovascular risk
José M Gatell, Lambert Assoumou, Graeme Moyle, et al.
Clinical Transplantation
|
December 2, 2017
Sofosbuvir plus daclatasvir with or without ribavirin is safe and effective for post-transplant hepatitis C recurrence and severe fibrosis and cirrhosis: A prospective study
Raffaella Lionetti, Vincenza Calvaruso, Paola Piccolo, et al.
The New England Journal of Medicine
|
August 9, 2008
HHV-6A in syncytial giant-cell hepatitis
Leonardo Potenza, Mario Luppi, Patrizia Barozzi, et al.
Viruses
|
December 23, 2023
Bone Mineral Density and Trabecular Bone Score Changes throughout Menopause in Women with HIV
Jovana Milic, Stefano Renzetti, Denise Morini, et al.
Nutrients
|
September 23, 2022
Modifications of Chest CT Body Composition Parameters at Three and Six Months after Severe COVID-19 Pneumonia: A Retrospective Cohort Study
Giulia Besutti, Massimo Pellegrini, Marta Ottone, et al.
HIV Clinical Trials
|
August 22, 2014
Relationship between health-related quality of life measures and high HIV viral load in HIV-infected triple-class-experienced patients
Raffaella Bucciardini, Katherina Pugliese, Liliana Weimer, et al.
Open Forum Infectious Diseases
|
January 19, 2026
Bimonthly Administered Long-Acting Cabotegravir and Rilpivirine Are Highly Effective and Well-Tolerated in People With Human Immunodeficiency Virus Above 65 Years
Andrea Calcagno, Caterina Candela, Agostino Riva, et al.
AIDS (London, England)
|
February 26, 2021
Dolutegravir is not associated with weight gain in antiretroviral therapy experienced geriatric patients living with HIV
Giovanni Guaraldi, Stefano Calza, Jovana Milic, et al.
Page
of 41